Association between Takayasu arteritis and ischemic heart disease: a cohort study.

Takayasu arteritis immune diseases ischemic heart disease vasculitis

Journal

Mediterranean journal of rheumatology
ISSN: 2529-198X
Titre abrégé: Mediterr J Rheumatol
Pays: Greece
ID NLM: 101730166

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 03 05 2019
revised: 22 09 2019
accepted: 27 09 2019
entrez: 19 3 2020
pubmed: 19 3 2020
medline: 19 3 2020
Statut: epublish

Résumé

Takayasu arteritis (TA) is an idiopathic large vessel vasculitis, which involves the aorta and its major branches. Our aim was to examine the association between TA and the development of ischemic heart disease (IHD) and its impact on survival. Using data from Clalit Health Services (CHS), the largest Health Maintenance Organization (HMO) in Israel, the proportion of IHD was compared between patients diagnosed with TA and age- and gender-matched controls. Chi-square and t-tests were used for univariate analysis, and a logistic regression model was employed for multivariate analysis. Survival analysis was performed using Kaplan-Meier plots and cox regression. The study included 155 TA patients and 755 age- and gender-frequency matched controls. The proportion of IHD in TA patients was increased in comparison with controls (32.3% and 8.9%, p<0.001). In multivariate analysis, IHD was associated with TA (OR=6.576, 95% CI: 4.09-10.64) and male gender (OR=2.29, 95% CI: 1.43-4.26). Survival analysis over 15 years of follow-up showed a higher proportion of all-causes mortality in the TA group. In a multivariate analysis, TA (HR=2.58, 95%CI: 1.64-4.06) and IHD (HR=1.64, 95%CI: 1.05-2.55) were found to be associated with reduced survival. TA patients present an increased proportion of IHD, and a reduced 15-years survival rate compared to controls.

Identifiants

pubmed: 32185361
doi: 10.31138/mjr.30.3.171
pii: MJR-30-3-171
pmc: PMC7045855
doi:

Types de publication

Journal Article

Langues

eng

Pagination

171-176

Informations de copyright

© 2019 The Mediterranean Journal of Rheumatology (MJR).

Références

Circulation. 2005 Nov 22;112(21):3337-47
pubmed: 16301360
Heart Vessels Suppl. 1992;7:26-31
pubmed: 1360966
Autoimmun Rev. 2007 Sep;6(8):566-71
pubmed: 17854750
Int J Cardiol. 2017 Jul 1;238:182
pubmed: 28449826
Am J Cardiol. 2014 Mar 1;113(5):881-7
pubmed: 24423899
Eur J Clin Invest. 2017 Jun;47(6):422-427
pubmed: 28382625
Int J Cardiol. 2017 Aug 15;241:41-45
pubmed: 28285799
Arthritis Rheum. 2007 Mar;56(3):1000-9
pubmed: 17328078
Rheum Dis Clin North Am. 2014 Feb;40(1):11-26
pubmed: 24268007
Radiology. 2014 Jan;270(1):74-81
pubmed: 24009351
J Rheumatol. 2013 Dec;40(12):2052-60
pubmed: 24128776
Ann Rheum Dis. 2006 Sep;65(9):1202-7
pubmed: 16439439
Am J Cardiol. 1991 Apr 15;67(9):879-82
pubmed: 1672784
Epidemiol Psychiatr Sci. 2017 Aug;26(4):424-429
pubmed: 27457404
Arthritis Rheum. 2009 Nov;60(11):3501-9
pubmed: 19877040
J Thorac Cardiovasc Surg. 2003 Mar;125(3):570-7
pubmed: 12658199
Acta Psychiatr Neurol Scand. 1951;26(3-4):313-37
pubmed: 14933169
J Rheumatol. 2013 Apr;40(4):493-7
pubmed: 23418378
Circulation. 1989 Sep;80(3):429-37
pubmed: 2569946
Eur J Intern Med. 2018 Jul;53:62-65
pubmed: 29631757
Circ J. 2012;76(4):1004-11
pubmed: 22301847
Medicine (Baltimore). 2016 Jul;95(27):e4069
pubmed: 27399093
Nat Rev Rheumatol. 2010 Jul;6(7):406-15
pubmed: 20596053
Eur J Nucl Med. 1990;16(3):173-8
pubmed: 1973100

Auteurs

Mathilde Versini (M)

Department of Internal Medicine, Archet-1 Hospital, University of Nice-Sophia-Antipolis, Nice, France.

Shmuel Tiosano (S)

Department of Medicine 'B', Sheba Medical Center, Tel Hashomer, Israel.
Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Israel.

Kassem Sharif (K)

Department of Medicine 'B', Sheba Medical Center, Tel Hashomer, Israel.
Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Israel.

Naim Mahroum (N)

Department of Medicine 'B', Sheba Medical Center, Tel Hashomer, Israel.
Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Israel.

Abdulla Watad (A)

Department of Medicine 'B', Sheba Medical Center, Tel Hashomer, Israel.
Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Israel.

Doron Comaneshter (D)

Department of Quality Measurements and Research, Chief Physician's Office, Clalit Health Services, Tel Aviv, Israel.

Guy Shalom (G)

Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Department of Dermatology and Venereology, Soroka Medical Center, Beer-Sheva, Israel.

Yehuda Shoenfeld (Y)

Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Israel.

Arnon D Cohen (AD)

Department of Quality Measurements and Research, Chief Physician's Office, Clalit Health Services, Tel Aviv, Israel.
Siaal Research Center for Family Medicine and Primary Care, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Howard Amital (H)

Department of Medicine 'B', Sheba Medical Center, Tel Hashomer, Israel.
Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Israel.

Classifications MeSH